Home | Business News | Browse by Publication | P | PR Newswire

Alpharma Receives USA FDA Tentative Approval for Lisinopril 20 mg, 30 mg and 40 mg Tablets.

Publication: PR Newswire
Publication Date: 12-MAR-02
Format: Online - approximately 396 words
Delivery: Immediate Online Access

Article Excerpt
FORT LEE, N.J. -- Alpharma Inc. today announced that Purepac Pharmaceutical Co., a subsidiary of Alpharma, has received tentative approval from the United States Food and Drug Administration (FDA) to manufacture and market lisinopril 20 mg, 30 mg and 40 mg tablets. Final approval is pending the expiration of pediatric exclusivity on June 29, 2002.

Alpharma's lisinopril tablets,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Foot Locker, Inc. 2001 Fourth Quarter and Full Year Earnings Conferenc..., March 12, 2002
Annual General Meeting at Novo Nordisk A/S., March 12, 2002
Philadelphia Stock Exchange to Begin Trading NetScreen Technologies In..., March 12, 2002
Pennsylvania Gov. Schweiker Announces 70 New Jobs, 215 Retained Jobs F..., March 12, 2002
Crown American Realty Trust Announces Final Settlement of State Shareh..., March 12, 2002

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.